Statements (36)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antihistamine
brand name drug |
| gptkbp:activeIngredient |
gptkb:cetirizine
|
| gptkbp:approvedBy |
1987
|
| gptkbp:ATCCode |
gptkb:R06AE07
|
| gptkbp:availableOn |
gptkb:government_agency
gptkb:sugar gptkb:tablet chewable tablet |
| gptkbp:brand |
gptkb:cetirizine
|
| gptkbp:contraindication |
severe renal impairment
hypersensitivity to cetirizine |
| gptkbp:excretion |
urine
|
| gptkbp:form |
chewable tablet
oral solution oral tablet |
| gptkbp:genericAvailable |
yes
|
| gptkbp:halfLife |
8.3 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zyrtec
|
| gptkbp:legalStatus |
over-the-counter
prescription-only (in some countries) |
| gptkbp:manufacturer |
gptkb:UCB
gptkb:Johnson_&_Johnson |
| gptkbp:marketedIn |
gptkb:Europe
gptkb:United_States |
| gptkbp:mechanismOfAction |
H1 receptor antagonist
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
fatigue
headache drowsiness dry mouth |
| gptkbp:usedFor |
allergic rhinitis
urticaria |
| gptkbp:bfsParent |
gptkb:Johnson_&_Johnson
|
| gptkbp:bfsLayer |
4
|